You are here

Bajpayee and Slavov Receive Sanofi iAwards

February 1, 2019

BioE Assistant Professors Ambika Bajpayee and Nikolai Slavov were each recipients of a $125K Sanofi iAward, which were created to promote scientific breakthroughs by tapping into the world’s greatest minds through close collaboration with renowned academic institutions. Bajpayee and Slavov were 2 of 29 selected through a competitive review process to receive grants. Professor Bajpayee’s project, entitled “Exosomes for oral delivery of Foxo1 SiRNA for treatment of Type I diabetes,” focuses on developing a non-invasive method of drug delivery for diabetes while Professor Slavov’s project, entitled “Developing a technology platform for discovering biomarkers and drug targets,” focuses on the use of technology including liquid chromatography and mass spectrometry to improve the diagnosis and treatment of cardiovascular and neurological diseases, cancer and diabetes.

iAwards is an invitation-only, multi-institutional academic partnership program designed for Sanofi to collaborate with academic investigators to quickly move promising early stage, disease relevant, innovative research towards the clinic. Seventeen academic institutions across North America are currently participating in this program. Through this program, Sanofi aims to fund innovative and translational research ideas that can contribute to its early stage pipeline and ultimately benefit patients.